ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA

John A. Martignetti; Olga Camacho-Vanegas; Nolan Priedigkeit; Catalina Camacho; Elena Pereira; Li Lin; Leopold Garnar-Wortzel; Dagny Miller; Bojan Losic; Hardik Shah; Jun Liao; Jian Ma; Pratik Lahiri; Mark Chee; Eric Schadt; Peter DottinoIcahn School of Medicine at Mount Sinai; new
Neoplasia2014-1-1DOI: 10.1593/neo.131900
42被引15阅读
引用收藏
分享

摘要

<br/>Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible. Here, we demonstrate that for one patient, with the first reported fibroblast growth factor receptor 2 (FGFR2) fusion transcript in ovarian cancer, circulating tumor DNA (ctDNA) is a more sensitive and specific biomarker than CA125, and it can also inform on a candidate therapeutic. For a 4-year period, during which the patient underwent primary debulking surgery and chemotherapy, tumor recurrences, and multiple chemotherapeutic regimens, blood samples were longitudinally collected and stored. Whereas postsurgical CA125 levels were elevated only three times for 28 measurements, the FGFR2 fusion ctDNA biomarker was readily detectable by quantitative real-time reverse transcription-polymerase chain reaction (PCR) in all of these same blood samples and in the tumor recurrences. Given the persistence of the FGFR2 fusion, we treated tumor cells derived from this patient and others with the FGFR2 inhibitor BGJ398. Only tumor cells derived from this patient were sensitive to FGFR2 inhibitor treatment. Using the same methodologic approach, we demonstrate in a second patient with a different fusion that PCR and agarose gel electrophoresis can also be used to identify tumor-specific DNA in the circulation. Taken together, we demonstrate that a relatively inexpensive, PCR-based ctDNA surveillance assay can outperform CA125 in identifying occult disease.

相关
加载中…
  • Personalized ovarian cancer surveillance and detection of a therapeutic drug target in circulating tumor DNA
    Martignetti, John A.; Camacho-Vanegas, Olga; Priedigkeit, Nolan; Camacho-Vanegas, Catalina; Pereira, Elena; Lin, Li; Losic, Bojan; Shah, Hardik; Liao, Jun; Ma, Jian; Lahiri, Pratik; Chee, Mark; Schadt, Eric; Dottino, Peter105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), San Diego, CA, 2014-04-05 To 2014-04-09.
  • Noninvasive early differential diagnosis and progression monitoring of ovarian cancer using the copy number alterations of plasma cell-free DNA
    Chen, Lu; Ma, Rong; Luo, Chang; Xie, Qin; Ning, Xin; Sun, Kaidi; Meng, Fanling*; Zhou, Meng*; Sun, Jie*Translational Research, 2023, 262: 12-24.被引 1
  • Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrence
    Gassa Asmae; Fassunke Jana; Schuetten Sarah; Kuhlmann Luca; Scherer Marie; Sun Jie; Zhao Yue; Michel Max; Loeser Heike; Wolf Juergen; Buettner Reinhard; Doerr Fabian; Heldwein Matthias; Hagmeyer Lars; Frank Konrad; Merkelbach Bruse Sabine; Quaas Alexander; Bruns Christiane J.; Alakus HakanLung Cancer, 2020, prepublish.
查看全部 →

发表信息

论文状态
公开发表
期刊
Neoplasia
发表日期
2014-01-01
卷期
第 16 卷, 第 1 期
页码
97-w29
DOI
10.1593/neo.131900
成果收录
SCIENCEDIRECT

作者

  • J

    John A. Martignetti (第一作者)

  • O

    Olga Camacho-Vanegas

查看全部 16 位作者收起作者
  • N

    Nolan Priedigkeit

  • C

    Catalina Camacho

  • E

    Elena Pereira

  • L

    Li Lin

  • L

    Leopold Garnar-Wortzel

  • D

    Dagny Miller

  • B

    Bojan Losic

  • H

    Hardik Shah

  • J

    Jun Liao

  • J

    Jian Ma

  • P

    Pratik Lahiri

  • M

    Mark Chee

  • E

    Eric Schadt

  • P

    Peter Dottino

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417